SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K


                             Current Report Pursuant
                          to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

     Date of Report (Date of earliest event reported) February 13, 2003

                             BOSTON BIOMEDICA, INC.
              ----------------------------------------------------
             (Exact Name Of Registrant As Specified In Its Charter)

                                  MASSACHUSETTS
                  --------------------------------------------
                 (State or Other Jurisdiction of Incorporation)

           0-21615                                    04-2652826
    ----------------------                ---------------------------------
   (Commission File Number)              (I.R.S.Employer Identification No.)

  375 West Street, West Bridgewater, MA                           02379
  --------------------------------------                        --------
 (Address of Principal Executive Offices)                      (Zip Code)

                                 (508) 580-1900
               --------------------------------------------------
              (Registrant's Telephone Number, Including Area Code)

                                       N/A
           -----------------------------------------------------------
          (Former Name or Former Address, if Changed Since Last Report)




<PAGE>


ITEM 5.           OTHER EVENTS
------

On February 14, 2003, Boston Biomedica,  Inc. announced that the Company's Board
of  Directors  had  terminated  Richard  T.  Schumacher  as  Chairman  and Chief
Executive  Officer.  A copy of the press  release  issued on  February  14, 2003
regarding the termination of Mr. Schumacher is filed as Exhibit 99.1.


ITEM 7.           EXHIBITS
------

Exhibit Number                  Description
--------------                  -----------
99.1                            Press Release dated February 14, 2003




                                   SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
Registrant  has duly  caused  this  Report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.


Dated: February 24, 2003                 BOSTON BIOMEDICA, INC.



                               By:       /s/ Kevin W. Quinlan
                                         --------------------------------------
                                         Kevin W. Quinlan,
                                         President and Chief Operating Officer
                                         and Treasurer



<PAGE>



                                INDEX TO EXHIBITS

  Exhibit
   Number                           Description
-----------   ------------------------------------------------------


   99.1       Press Release dated February 14, 2003
[{"type": "8-K", "sequence": "1", "filename": "form8kbody.txt", "description": "8K FILING RE: TERMINATION OF CEO", "secsgml_size_bytes": 3005}]
{"company-data": {"conformed-name": "BOSTON BIOMEDICA INC", "cik": "0000830656", "assigned-sic": "2835", "irs-number": "042652826", "state-of-incorporation": "MA", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-21615", "film-number": "03577423"}, "business-address": {"street1": "375 WEST STREET", "city": "WEST BRIDGEWATER", "state": "MA", "zip": "02379", "phone": "5085801900"}, "mail-address": {"street1": "375 WEST ST", "city": "WEST BRIDGEWATER", "state": "MA", "zip": "02379"}}
SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                             Current Report Pursuant
                          to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

     Date of Report (Date of earliest event reported) February 13, 2003

                             BOSTON BIOMEDICA, INC.
              ----------------------------------------------------
             (Exact Name Of Registrant As Specified In Its Charter)

                                  MASSACHUSETTS
                  --------------------------------------------
                 (State or Other Jurisdiction of Incorporation)

           0-21615                                    04-2652826
    ----------------------                ---------------------------------
   (Commission File Number)              (I.R.S.Employer Identification No.)

  375 West Street, West Bridgewater, MA                           02379
  --------------------------------------                        --------
 (Address of Principal Executive Offices)                      (Zip Code)

                                 (508) 580-1900
               --------------------------------------------------
              (Registrant's Telephone Number, Including Area Code)

                                       N/A
           -----------------------------------------------------------
          (Former Name or Former Address, if Changed Since Last Report)
ITEM 5.           OTHER EVENTS
------

On February 14, 2003, Boston Biomedica,  Inc. announced that the Company's Board
of  Directors  had  terminated  Richard  T.  Schumacher  as  Chairman  and Chief
Executive  Officer.  A copy of the press  release  issued on  February  14, 2003
regarding the termination of Mr. Schumacher is filed as Exhibit 99.1.

ITEM 7.           EXHIBITS
------

Exhibit Number                  Description
--------------                  -----------
99.1                            Press Release dated February 14, 2003

                                   SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
Registrant  has duly  caused  this  Report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

Dated: February 24, 2003                 BOSTON BIOMEDICA, INC.

                               By:       /s/ Kevin W. Quinlan
                                         --------------------------------------
                                         Kevin W. Quinlan,
                                         President and Chief Operating Officer
                                         and Treasurer
INDEX TO EXHIBITS

  Exhibit
   Number                           Description
-----------   ------------------------------------------------------

   99.1       Press Release dated February 14, 2003